A large British study published on Wednesday found Regeneron Pharmaceuticals Inc’s COVID-19 antibody cocktail reduces deaths in hospitalised patients who have not mounted their own antibody response.

Regeneron COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies: Study

randomised-evaluation-of-covid-19-therapy-trial

Randomised Evaluation Of Covid 19 Therapy Trial, News on Randomised Evaluation Of Covid 19 Therapy Trial, stories on Randomised Evaluation Of Covid 19 Therapy Trial, articles on Randomised Evaluation Of Covid 19 Therapy Trial, Randomised Evaluation Of Covid 19 Therapy Trial stories at Wion, Randomised Evaluation Of Covid 19 Therapy Trial news, Randomised Evaluation Of Covid 19 Therapy Trial latest news

randomised evaluation-of-covid-19-therapy-trial

Regeneron COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies: Study